Diabetes in old age: An emerging epidemic

Journal of Association of Physicians of India

Volumn 51, Issue NOV, 2003, Pages 1083-1094

  Kesavadev, J D ^b   Short, K R ^a   Sreekumaran Nair, K ^a  

^a MAYO CLINIC   (United States)

^b Indian Institute of Diabetes   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; AGED; AGING; HEALTH; HUMAN; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; PATHOPHYSIOLOGY; PATIENT EDUCATION; REVIEW; RISK FACTOR;

AGE FACTORS; AGED; AGING; DIABETES MELLITUS, TYPE 2; HUMANS; MIDDLE AGED; PATIENT EDUCATION; RISK FACTORS; WORLD HEALTH;

EID: 4344677161     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (98)

1. Meneilly GS, Tessier D. Diabetes in elderly adults. J Gerontol A Biol Sci Med Sci 2001;56:M5-13.
2. MI Harris, CC Cowie, MS Eberhardt. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 1998;21:518-24.
3. DeFronzo RA, Simonson D. Diabetes in the elderly: Not just "normal aging". Geriatrics 1984;39:16-9.
4. Spence JW. Some observations on sugar tolerance with special referance to variations found at different ages. Quat J Med 1920;14:314-26.
5. American Diabetes Association. Nutrition recommendations and principles for people with diabetes mellitus. Diabetes Care 1994;17:519-522.
6. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
7. UK Prospective Diabetes Study (UKPDS). XI: Biochemical risk factors in type 2 diabetic patients at diagnosis compared with age-matched normal subjects. Diabet Med 1994;11:534-44.
8. Endocrine disorders in Elderly. In Clinical Geriatrics. 1 ed. Dharmarajan TS, Robert A Norman, Eds. 2003:447-53.
9. Population Ageing - a public health challenge(WHO). http://www.who.int/ inf-fs/en/fact135.html 1998.
10. Ramachandran A, Snehalatha C, Kapur A, Vijay V, Mohan V, Das AK, Rao PV, Yajnik CS, Prasanna Kumar KM, Nair JD. Diabetes Epidemiology Study Group in India (DESI) : High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia 2001;44:1094-1101.
11. Global burden of diabetes(WHO). http://www.who.int/inf-pr-1998/en/pr98- 63.html 1998.
12. Rao PV, Ahuja MM, Trivedi BB, Ramachandran M, Samal KC, Zain AZ, Charles C. Age: the most significant risk for diabetes in Indian populations. J Indian Med Assoc 1998;96:155-7.
13. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998;21:1414-31.
14. Gupta HL, Yadav M, Sundarka MK, Talwar V, Saini M, Garg P: A study of prevalence of health problems in asymptomatic elderly individuals in Delhi. J Assoc Physicians India 2002;50:792-5.
15. Rao PV, Ushabala P, Seshiah V, Ahuja MM, Mather HM. The Eluru survey: prevalence of known diabetes in a rural Indian population.[comment]. Diab Res Clin Pract 1989;7:29-31.
16. Raman K, V, Joseph A, Soman CR. High prevalence of type 2 diabetes in an urban settlement in Kerala, India. Ethn Health 1999;4:231-9.
17. Cheah JS, Wang KW, Sum CF: Epidemiology of diabetes mellitus in the Asia-Pacific region. Ann Acad Med Singapore 1990;19:501-5.
18. Ramachandran A, Jali MV, Mohan V, Snehalatha C, Viswanathan M: High prevalence of diabetes in an urban population in south India. BMJ 297:587-590, 1988
19. Sicree RA, Ram P, Zimmet P, Cabealawa S, King H. Mortality and health service utilization amongst Melanesian and Indian diabetics in Fiji. Diabetes Res Clin Pract 1985;1:227-34.
20. American Diabetes Association: Diabetes and Seniors. http://www.diabetes. org/main/info/risk/default5.jsp 2003.
21. Das AK, Talwalkar PG. Diabetes Mellitus. In Geriatric Care in India. Sharma O.P, Ed. 1999:281-91.
22. Bourey RE, Kohrt WM, Kirwan JP, Staten MA, King DS, Holloszy JO. Relationship between glucose tolerance and glucose-stimulated insulin response in 65-year-olds. J Gerontol: Medical Sciences 1993;48:M122-M127.
23. Short KR, Nair KS. Muscle protein metabolism and the sarcopenia of aging. Internat J Sport Nutr and Exercise Met 2001;11:Suppl-27.
24. Colditz GA, Willett WC, Stampfer MJ, Manson JE, Hennekens CH, Arky RA, Speizer FE. Weight as a risk factor for clinical diabetes in women. Am J Epidemiol 1990;132:501-13.
25. Elahi D, Muller DC, Tzankoff SP, Andres R, Tobin JD. Effect of age and obesity on fasting levels of glucose, insulin, glucagon, and growth hormone in man. J Gerontol 1982;37:385-91.
26. Holloszy JO, Kohrt WM. Exercise. In: Ed. EJ Masoro Handbook of physiology - Physiology of Aging. 1995;24:633-66.
27. Shimokata H, Muller DC, Fleg JL, Sorkin J, Ziemba AD, Andres R. Age as independent determinant of glucose tolerance. Diabetes 1991;40:44-51.
28. Short KR, Janet L Vitonne, Maureen L Bigelow, David N Proctor, Robert A Rizza, Nair KS. Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity. Diabetes 2003;52:1888-96.
29. Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, Cline GW, Shulman GI: Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 2003;300:1140-2.
30. Rooyackers OE, Adey DB, Ades PA, Nair KS: Effect of age on in vivo rates of mitochondrial protein synthesis in human skeletal muscle. Proc Natl Acad Sci USA 1996;93:15364-9.
31. Sreekumar R, Halvatsiotis P, Schimke JC, Nair KS. Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment. Diabetes 2002;51:1913-20.
32. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E, Houstis N, Daly MJ, Patterson N, Mesirov JP, Golub TR, Tamayo P, Spiegelman B, Lander ES, Hirschhorn JN, Altshuler D, Groop LC: PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003;34:267-73.
33. Stump CS, Short KR, Bigelow ML, Schimke JM, Nair KS: Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts. Proc Natl Acad Sci USA 2003;100:7996-8001.
34. Halvatsiotis P, Short KR, Bigelow M, Nair KS: Synthesis rate of muscle proteins, muscle functions, and amino acid kinetics in type 2 diabetes. Diabetes 2002;51:2395-2404.
35. Gloyn AL. The search for type 2 diabetes genes. Ageing Res Rev 2003;2:111-27.
36. Quinn L. Behavior and biology: the prevention of type 2 diabetes. J Cardiovasc Nurs 2003;18:62-8.
37. Bougneres P. Genetics of obesity and type 2 diabetes: tracking pathogenic traits during the predisease period. Diabetes 2002;51 Suppl 3:S295-S303.
38. Ghosh S, Schork NJ. Genetic analysis of NIDDM. The study of quantitative traits. Diabetes 1996;45:1-14.
39. Permutt MA, Chiu K, Ferrer J, Glaser B, Inoue H, Nestorowicz A, Stanley CA, Tanizawa Y. Genetics of type II diabetes. Recent Prog Horm Res 1998;53:201-16.
40. Morley JE. The elderly Type 2 diabetic patient: special considerations. Diabet Med 1998;15 Suppl 4:S41-S46.
41. Edwards BJ, Morley JE: Amylin. Life Sci 1992;51:1899-1912.
42. Elahi D, Muller DC: Carbohydrate metabolism in the elderly. Eur J Clin Nutr 2000;54 Suppl 3:S112-S120.
43. Basu R, Breda E, Oberg A L, Dalla Man C, Basu A, Vittone JL, Klee GG, Arora P, Jensen MD, Toffolo G, Cobelli C, Rizza RA. Mechanisms of age-associated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action and clearance. Diabetes 2003;52:1738-48.
44. DeFronzo RA: Glucose intolerance and aging. Diabetes Care 1981;4:493-501.
45. Alvin C Powers. Diabetes Mellitus. In Harrisons Principles of Internal Medicine. 15 ed. Eugene Braunwald, Anthony S.Fauci, Kurt J.Isselbacher, Dennis L.Kasper, Stephen L.Hauser, Dan L.Longo, J.Larry Jameson, Eds. 2001:37.
46. Bennet G: Examination of Elderly People. In Hutchison's Clinical Methods . 20 ed. Michael Swash, Ed. 1995:388.
47. Balkau B: The DECODE study. Diabetes epidemiology: collaborative analysis of diagnostic criteria in Europe. Diabetes Metab 2000;26:282-6.
48. Consequences of the new diagnostic criteria for diabetes in older men and women. DECODE Study (Diabetes Epidemiology: Collaborative Analysis of Diagnostic Criteria in Europe). Diabetes Care 1999;22:1667-71.
49. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe. Lancet 1999;354:617-21.
50. Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies. The DECODE-study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis of Diagnostic Criteria in Europe. Diabetologia 1999;42:647-54.
51. Balkau B. New diagnostic criteria for diabetes and mortality in older adults. DECODE Study Group. European Diabetes Epidemiology Group. Lancet 1999;353:68-9.
52. Gregg EW, Engelgau MM, Narayan V: Complications of diabetes in elderly people. BMJ 2002;325:916-7.
53. Fontbonne A, Berr C, Ducimetiere P, Alperovitch A. Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the epidemiology of vascular aging study. Diabetes Care 2001;24:366-70.
54. Haan MN, Shemanski L, Jagust WJ, Manolio TA, Kuller L. The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. JAMA 1999;282:40-6.
55. Edward W, Gregg P, Arleen Brown MP. Cognitive and physical disabilities and aging-related complications of diabetes. Clinical Diabetes 2003;21:113-8.
56. Gregg EW, Beckles GL, Williamson DF, Leveille SG, Langlois JA, Engelgau MM ea: Diabetes and physical disability among US adults. Diabetes Care 2000;23:1272-7.
57. Schwartz AV, Sellmeyer DE, Ensrud KE, Cauley JA, Tabor HK, Schreiner PJ eal. Older women with diabetes have an increased risk of fracture: a prospective study. J Clin Endocrinol Metab 2001;86:32-38.
58. Disorders of Carbohydrate Metabolism. The Merck Manual Of Geriatrics 2003;Chapter 64.
59. Fain JA: Diabetes prevention program: education is vital. Diabetes Educ 2002;28:474.
60. Diet and exercise dramatically delay type 2 diabetes. Health Care Financ Rev 2001;23:181-2.
61. Doggrell SA. Metformin and lifestyle intervention prevent Type 2 diabetes: lifestyle intervention has the greater effect. Expert Opin Pharmacother 2002;3:1011-3.
62. Yale JF. Prevention of type 2 diabetes. Int J Clin Pract Supp2000;135-9.
63. Kirwin JP, Khort WM, Wojta DM, Bourey RE, Holloszy JO. Endurance exercise training reduces glucose-stimulated insulin levels in 60- to 70-year old men and women. Journal of Gerontology 1993:M84 -M90.
64. Clevenger CM, Jones PP, Tanaka H, Seals DR, DeSouza CA. Decline in insulin action with age in endurance-trained humans. J Appli Physiol 2002;93:2105-11.
65. Dengel DR, Pratley RE, Hagberg JM, Rogus EM, Goldberg AP. Distinct effects of aerobic exercise training and weight loss on glucose homeostasis in obese sedentary men. J Appl Physiol 1996;81:318-25.
66. Glynn RJ, Monane M, Gurwitz JH, Choodnovskiy I, Avorn J. Aging, comorbidity, and reduced rates of drug treatment for diabetes mellitus. J Clini Epidemiol 1999;52:781-90.
67. Chin MH, Su AW, Jin L, Nerney MP. Variations in the care of elderly persons with diabetes among endocrinologists, general internists, and geriatricians. J Gerontol A Biol Sci Med Sci 2000;55:M601-M606.
68. Chin MH, Zhang JX, Merrell K. Specialty differences in the care of older patients with diabetes. Med Care 2000;38:131-40.
69. California Health Care foundation/American Geriatrics Society Panel on improving Care of Elders with Diabetes: Guidelines for Improving the Care of the Older Person with Diabetes Mellitus. J Am Geriatri Soc 2003;51:265-80.
70. American Diabetes Association. Tight Diabetes Control. http://www.diabetes.org/main/type1/medical/blood_sugar/default3.jsp 2003.
71. Rosenstock J: Management of type 2 diabetes mellitus in the elderly: special considerations. Drugs Aging 2001;18:31-44.
72. Sinclair AJ: Diabetes in old age - changing concepts in the secondary care arena. J Royal Coll Physicians Lond 2000;34:240-4.
73. Graal MB, Wolffenbuttel BH. The use of sulphonylureas in the elderly. Drugs and Aging 1999;15:471-81.
74. Nicollerat JA: Implications of the United Kingdom Prospective Diabetes Study (UKPDS) results on patient management. Diabetes Educ 2000;26 Suppl:8-10.
75. Yki-Jarvinen H. Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus. Diabetes Metab Res Rev 2002;18 Suppl 3:S77-S81.
76. Beyth RJ, Shorr RI. Epidemiology of adverse drug reactions in the elderly by drug class. Drugs and Aging 1999;14:231-9.
77. Antiplatelet Trialists' Collaboration. Collaborative overview of ran-domised trials of antiplatelet therapy-I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various catego-ries of patients. BMJ-1994;81:159-68.
78. Mudaliar S, Edelman SV. Insulin therapy in type 2 diabetes. Endocrinol. Metab Clin North Am 2001;30:935-82.
79. Wilson MG, Kaiser FE, Morley JE. Tablet-breaking ability of older persons with type 2 diabetes mellitus. Diabetes Educ 2001;27:530-40.
80. Graal MB, Wolffenbuttel BH: The use of sulphonylureas in the elderly. Drugs Aging 1999;15:471-81.
81. Langtry HD, Balfour JA: Glimepiride. A review of its use in the management of type 2 diabetes mellitus. Drugs 1998;55:563-84.
82. U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. UK Prospective Diabetes Study Group. Diabetes 1995;44:1249-58.
83. Saudek CD, Hill GS: Feasibility and outcomes of insulin therapy in elderly patients with diabetes mellitus. Drugs Aging 1999;14:375-85.
84. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr, Jones DW, Materson BJ, Oparil S, Wright JT, Jr., Roccella EJ. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-2572.
85. Girerd X, Hanon O. [Benefits of hypertension treatment in the elderly]. Ann Cardiol Angeiol (Paris) 1999;48:518-22.
86. Weber MA: Outcomes of treating hypertension in the elderly: a short commentary on current issues. Am J Geriatr Cardiol 2003;12:14-8.
87. Vidt DG. Good news for the older patient with diabetes: added cardiovascular risk reduction. Curr Hypertens Rep 1999;1:379-80.
88. Vidt DG, Pohl MA. Aggressive blood pressure lowering is safe, but benefit is still hard to prove. Cleve Clin J Med 1999;66:105-11.
89. Mazza A, Pessina AC, Pavei A, Scarpa R, Tikhonoff V, Casiglia E. Predictors of stroke mortality in elderly people from the general population. The CArdiovascular STudy in the ELderly. Eur J Epidemiol 2001;17:1097-1104.
90. American Diabetes Association. Management of dyslipidemia in adults with diabetes. Diabetes Care 2003;26:S83-86.
91. Anonymous: Statins safe for elderly patients. New findings offer reassurance about the cholesterol drugs. Heart Advis 2003;6:3.
92. Allen Maycock CA, Muhlestein JB, Horne BD, Carlquist JF, Bair TL, Pearson RR, Li Q, Anderson JL. Statin therapy is associated with reduced mortality across all age groups of individuals with significant coronary disease, including very elderly patients. J Am Coll Cardiol 2002;40:1777-85.
93. Poland, GA Adult Immunization. American Geriatrics Society, 2003.
94. Immunization and the Prevention of Influenza and Pneumococcal Disease in People With Diabetes. Diabetes Care 2003;26:S126-8.
95. Critchley JA, Capewell S: Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA 2003;290:86-97.
96. Sharma SP, Peter Xenos. "Aging in India" Demographic background and analysis based on 'census materials' Occasional paper no:2 of 1992. 1992. office of the registrar general and census commissioner, India, New Delhi.
97. Ramachandran A, et al. National Urban Diabetes Survey, India. Diabetologia 2001;44:1094-1101.
98. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM, Byrd-Holt DD. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 1998;21:475-6.